IMP/CTM Information Required for Regulatory Filings (WS30)
- Date:
- 3 May 2022
- Time:
- -
- Available Seats:
- 60
The CMC section of the IND/IMPD contains information that has a direct impact on clinical trial supplies. Failure to prepare IMP that follows the requirements listed in this section can have a significant impact on a clinical trial. This session will discuss the CMC information contained in a clinical trial regulatory filing and how it should be monitored to avoid issues with clinical supplies.
